FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

13631511000001106: Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
48524301000001113 Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70048101000001110 Kaletra 100mg/25mg tablets (AbbVie Ltd) 60 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Is a Lopinavir 100mg / Ritonavir 25mg tablets 60 tablet true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Is pack of Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) false Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has active ingredient Ritonavir false Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has active ingredient Lopinavir false Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has AMP Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has specific active ingredient Ritonavir true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has specific active ingredient Lopinavir true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Kaletra 100mg/25mg tablets (Abbott Laboratories Ltd) 60 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start